Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.5

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.5

Views

Views
November 20230
December 20231
January 20241
February 20240
March 20242
April 20240
May 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Boardman2
Ashburn1